Temasek Holdings (Private) LTD Beam Therapeutics Inc. Transaction History

Temasek Holdings (Private) LTD

  • $24.5 Billion
  • Q3 2024

A detailed history of Temasek Holdings (Private) LTD transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Temasek Holdings (Private) LTD holds 1,812,972 shares of BEAM stock, worth $52.2 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,812,972
Holding current value
$52.2 Million
% of portfolio
0.18%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$22.57 - $33.14 $40.9 Million - $60.1 Million
1,812,972 New
1,812,972 $44.4 Million
Q1 2024

May 15, 2024
SELL
$23.46 - $45.07 $29.6 Million - $56.9 Million
-1,263,145 Reduced 41.06%
1,812,972 $59.9 Million
Q4 2023

Feb 14, 2024
SELL
$17.69 - $30.76 $22 Million - $38.2 Million
-1,241,672 Reduced 28.76%
3,076,117 $83.7 Million
Q2 2023

Aug 14, 2023
BUY
$29.32 - $35.99 $6.55 Million - $8.04 Million
223,277 Added 5.45%
4,317,789 $138 Million
Q1 2023

May 15, 2023
BUY
$30.15 - $48.79 $36.7 Million - $59.3 Million
1,216,215 Added 42.25%
4,094,512 $125 Million
Q4 2022

May 15, 2023
BUY
$36.73 - $51.6 $441,825 - $620,696
12,029 Added 0.42%
2,878,297 $113 Million
Q4 2022

Feb 14, 2023
BUY
$36.73 - $51.6 $441,825 - $620,696
12,029 Added 0.42%
2,878,297 $113 Million
Q3 2022

May 15, 2023
SELL
$39.79 - $70.31 $43.5 Million - $76.8 Million
-1,092,944 Reduced 27.61%
2,866,268 $137 Million
Q3 2022

Apr 05, 2023
SELL
$39.79 - $70.31 $478,633 - $845,758
-12,029 Reduced 0.42%
2,866,268 $137 Million
Q3 2022

Nov 14, 2022
SELL
$39.79 - $70.31 $43.5 Million - $76.8 Million
-1,092,944 Reduced 27.61%
2,866,268 $137 Million
Q1 2022

May 15, 2023
BUY
$53.73 - $82.16 $58.1 Million - $88.8 Million
1,080,915 Added 37.55%
3,959,212 $227 Million
Q1 2022

May 16, 2022
BUY
$53.73 - $82.16 $27 Million - $41.2 Million
501,827 Added 14.51%
3,959,212 $227 Million
Q2 2021

Aug 16, 2021
BUY
$64.12 - $128.71 $3.29 Million - $6.61 Million
51,372 Added 1.51%
3,457,385 $445 Million
Q1 2021

May 17, 2021
BUY
$71.28 - $120.75 $3.66 Million - $6.2 Million
51,372 Added 1.53%
3,406,013 $273 Million
Q1 2020

May 15, 2020
BUY
$13.31 - $29.2 $44.7 Million - $98 Million
3,354,641 New
3,354,641 $60.4 Million

Others Institutions Holding BEAM

# of Institutions
236
Shares Held
75.2M
Call Options Held
438K
Put Options Held
232K
View Full List

About Beam Therapeutics Inc.

BEAM Quotes by TradingView
  • Ticker BEAM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,354,600
  • Market Cap $2.03B
  • Description
  • Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...
More about BEAM
Track This Portfolio

Track Temasek Holdings (Private) LTD Portfolio

Follow Temasek Holdings (Private) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Temasek Holdings (Private) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Temasek Holdings (Private) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email